Resmed (RMD) EBITDA Margin (2009 - 2026)
Resmed's EBITDA Margin was 33.72% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 4.72 percentage points from 38.44% a year earlier and down 5.32 percentage points from the prior quarter.
Powered by 
Analysis
Resmed (RMD) EBITDA Margin (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), EBITDA Margin at Resmed came in at 36.93%, up 0.33 percentage points from FY2025.
- EBITDA Margin has now increased for three consecutive fiscal years, with a five-year change of +3.76 percentage points (FY2021 to FY2026).
- In earlier fiscal years, EBITDA Margin was 36.61% in FY2025 (+4.66 pp), 31.95% in FY2024 (+1.23 pp), 30.71% in FY2023 (-1.70 pp) and 32.42% in FY2022 (-0.76 pp).
- The fiscal Q4 2026 figure marks the lowest quarterly EBITDA Margin since fiscal Q2 2024.
- Compared with a year earlier, EBITDA Margin was higher in seven of the last eight quarters, with an average year-over-year change of +2.54 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q2 2025 (a gain of 8.66 percentage points); the worst was fiscal Q4 2026 (a drop of 4.72 percentage points).
- Per Business Quant data, RMD's EBITDA Margin in the three fiscal quarters before Q4 2026 was 39.04% (Q3 2026), 38.06% (Q2 2026) and 37.01% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 31.93% |
| 10 | Resmed | 35.85 Bn | 29.92 Bn | 861.22 Mn | 33.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.72% |
| Mar 31, 2026 | 39.04% |
| Dec 31, 2025 | 38.06% |
| Sep 30, 2025 | 37.01% |
| Jun 30, 2025 | 38.44% |
| Mar 31, 2025 | 36.38% |
| Dec 31, 2024 | 36.17% |
| Sep 30, 2024 | 35.28% |
| Jun 30, 2024 | 34.74% |
| Mar 31, 2024 | 34.93% |
| Dec 31, 2023 | 27.51% |
| Sep 30, 2023 | 30.29% |
| Jun 30, 2023 | 28.70% |
| Mar 31, 2023 | 30.89% |
| Dec 31, 2022 | 30.76% |
| Sep 30, 2022 | 32.83% |
| Jun 30, 2022 | 32.01% |
| Mar 31, 2022 | 31.99% |
| Dec 31, 2021 | 32.35% |
| Sep 30, 2021 | 33.30% |
API Access
Resmed EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();